CSIMarket Company Name, Ticker, Competitors, else..
 
Verve Therapeutics Inc   (NASDAQ: VERV)
 

VERV's Market share relative to its competitors, as of Q1 2025

As of Q1 2025 (Revenue in Millions of $)

Date modified: 2026-05-28T05:56:15+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months
Q1 2025		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE
A Quarter Before
Q4 2024
Verve Therapeutics Inc 59.61 0.58% 1.06 % 0.47 %
Alnylam Pharmaceuticals Inc 4,286.92 41.74% 41.60% 41.76%
United Therapeutics Corporation 3,169.80 30.87% 25.24% 27.96%
Apellis Pharmaceuticals Inc 1,105.28 10.76% 8.64% 7.15%
Ultragenyx Pharmaceutical Inc 669.71 6.52% 6.90% 4.87%
Bridgebio Pharma Inc 579.96 5.65% 7.85% 6.96%
41 more competitors available

Sign in to see all competitors for Verve Therapeutics Inc .

Sign In Create Free Account



VERV's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Verve Therapeutics Inc 0.59% 0.25% 1.07 % 0.48 %
Alnylam Pharmaceuticals Inc 42.53% 28.45% 42.02% 42.44%
United Therapeutics Corporation 31.44% 24.38% 25.50% 28.41%
Apellis Pharmaceuticals Inc 10.96% 7.69% 8.73% 7.27%
Ultragenyx Pharmaceutical Inc 6.64% 5.16% 6.97% 4.94%
Bridgebio Pharma Inc 5.75% 3.85% 7.93% 7.07%
36 more companies available

Sign in to see all industry competitors for Verve Therapeutics Inc .

Sign In Create Free Account



VERV's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Verve Therapeutics Inc 0.58% 0.24% 1.06 % 0.47 %
Alnylam Pharmaceuticals Inc 41.74% 28.05% 41.60% 41.76%
United Therapeutics Corporation 30.87% 24.04% 25.24% 27.96%
Apellis Pharmaceuticals Inc 10.76% 7.58% 8.64% 7.15%
Ultragenyx Pharmaceutical Inc 6.52% 5.08% 6.90% 4.87%
Bridgebio Pharma Inc 5.65% 3.79% 7.85% 6.96%
41 more companies available

Sign in to see all sector competitors for Verve Therapeutics Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Verve Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Verve Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.